Anzeige
❌
Mehr »
Sonntag, 22.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PB

WKN: A12FJ4 | ISIN: AU000000PAR5 | Ticker: P86
Lang & Schwarz
20.11.26 | 07:00
0,156 Euro
-100,00 % -0,156
Branche
Pharma
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
PARADIGM BIOPHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
PARADIGM BIOPHARMACEUTICALS LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
0,1510,16120.11.

Aktuelle News zur PARADIGM BIOPHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PARADIGM BIOPHARMACEUTICALS Aktie jetzt für 0€ handeln
MiPARADIGM BIOPHARMACEUTICALS LIMITED: Independent Review Supports New iPPS ROW Trial1
30.10.PARADIGM BIOPHARMACEUTICALS LIMITED: September 2026 Quarterly Activities Report & Appendix 4C4
28.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Convening Period Extended to 27 January 20271
22.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Deferral of AGM and Financial Reporting Obligations1
22.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Notification of cessation of securities - PAR-
22.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Notification of cessation of securities - PAR-
22.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Further Agreed Convertible Note Redemption1
22.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Extension of Convening Period1
15.10.PARADIGM BIOPHARMACEUTICALS LIMITED: PPS Shows Significant Pain Benefit in Rest of World Analysis17
12.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Expiry of PAROB Listed Options5
08.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Notification of cessation of securities - PAR1
08.10.PARADIGM BIOPHARMACEUTICALS LIMITED: Update on Data Review and Convertible note redemption1
30.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Continuation of Suspension from Quotation-
30.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Appointment of Voluntary Administrators1
30.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Board Initiates Voluntary Administration-
28.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Continuation of Voluntary Suspension6
24.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Notification of cessation of securities - PAR5
24.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Agreement to Return US$2M to Obsidian3
23.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Phase 3 Interim Result Below Continuation Threshold7
23.09.PARADIGM BIOPHARMACEUTICALS LIMITED: Suspension from Quotation6
1 2 3 4 Weiter >>
67 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1